Policy & Regulation
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
1 April 2026 - Thermo Fisher Scientific Inc (NYSE: TMO) announced on Wednesday that it has unveiled its next-generation Gibco CHOvantage GS Cell Line Development (CLD) Kit, an integrated platform desi...
Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal
1 April 2026 - Frontier Medicines Corporation, a clinical-stage precision medicines company, announced on Wednesday that it has entered into an exclusive licensing agreement with South Korean chemical...
NJ Bio and Aji Bio-Pharma partner to strengthen support for ADC development
1 April 2026 - NJ Bio Inc, a US-based provider of integrated drug discovery and development services, and Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a Japan-based provider of biopharmaceutical ma...
Alltrna granted approval for first-in-human clinical trial of AP003
1 April 2026 - Transfer RNA (tRNA) developer Alltrna announced on Tuesday that it has received approval to initiate a Phase 1 clinical trial of AP003 in healthy volunteers in Australia.The study has b...
Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share
...
Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management
31 March 2026 - Cell-free DNA testing company Natera Inc (NASDAQ:NTRA) on Tuesday reported publication of a prospective study in Clinical Cancer Research demonstrating that its Signatera molecular res...